In a strategic move poised to reshape the landscape of Central Nervous System (CNS) medication accessibility in India, Sanofi India Limited (SIL) and Cipla Limited today unveiled their exclusive partnership. This collaboration focuses on the distribution and promotion of Sanofi India’s CNS product range, including the renowned anti-epileptic medication, Frisium. Under the terms of the […]
In a significant development within the global healthcare industry, Apollo Hospitals Enterprise, recognized as one of the world’s largest vertically integrated healthcare providers, has announced the appointment of Dr. Madhu Sasidhar as President of its hospital division. This strategic move is aimed at further enhancing the group’s commitment to delivering world-class clinical outcomes and patient […]
The Kroger Co. (NYSE: KR) has announced a definitive agreement for the sale of its specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health, marking a significant transaction in the healthcare industry. The deal is poised to reshape Kroger’s involvement in specialty pharmacy services, underscoring the company’s strategic evaluation of its assets to enhance […]
In a groundbreaking development for the healthcare industry, CureMatch and Spesana have announced a strategic partnership aimed at advancing precision medicine and transforming patient care solutions for clinicians and patients. This collaboration seeks to integrate CureMatch’s innovative Knowledge Representation and Reasoning (KRR) AI precision medicine platform with Spesana’s clinical workflow ecosystem, promising to revolutionize patient […]
Swiss pharmaceutical giant Novartis has announced encouraging results from the TRANSITION phase 4 clinical trial, affirming that Entresto (sacubitril/valsartan) can be safely initiated early in a broad range of patients with heart failure with reduced ejection fraction (HFrEF), shortly after stabilization from an acute heart failure episode. This groundbreaking study underlines the effectiveness of Entresto […]